Microba Life Sciences Ltd News

Microba Life Sciences Ltd: Notification regarding unquoted securities - MAP

Feb 14 01:05 ET

Microba Life Sciences Ltd: Q2 FY25 Quarterly Investor Presentation & Webinar

Jan 28 16:58 ET

Microba Life Sciences Ltd: Q2 FY25 Quarterly Activities Report & Appendix 4C

Jan 28 16:55 ET

Microba Life Sciences Ltd: Details of Q2 FY25 Quarterly Report, Appendix 4C & Webinar

Jan 22 17:38 ET

Microba Life Sciences Ltd: Becoming a substantial holder

Jan 2 20:42 ET

Microba Life Sciences Ltd: Amended Constitution

Nov 29, 2024 02:00 ET

Microba Life Sciences Ltd: Results of Annual General Meeting

Nov 28, 2024 23:17 ET

Microba Life Sciences Ltd: 2024 Annual General Meeting Presentation

Nov 28, 2024 19:03 ET

Microba Life Sciences Ltd: Chair, Deputy Chair and CEO Addresses to AGM

Nov 28, 2024 19:01 ET

Microba Life Sciences Ltd: Trading Update

Nov 28, 2024 17:04 ET

Microba Life Sciences Ltd: Change of Director's Interest Notice - Pasquale Rombola

Nov 19, 2024 17:04 ET

Microba Life Sciences Ltd: Change of Director's Interest Notice - Prof Ian Frazer

Nov 19, 2024 17:02 ET

Microba Life Sciences Ltd: Bell Potter Healthcare Conference Presentation

Nov 18, 2024 17:14 ET

Microba Life Sciences Ltd: Microba receives $6 million R&D Tax Incentive Refund

Nov 17, 2024 17:08 ET

Microba Life Sciences Ltd: Release of Securities from Voluntary Escrow

Nov 11, 2024 01:35 ET

Microba Life Sciences Ltd: Q1 FY25 Quarterly Activities Report & Appendix 4C

Oct 28, 2024 18:15 ET

Microba Life Sciences Ltd: Q1 FY25 Quarterly Investor Presentation

Oct 28, 2024 18:15 ET

Microba Life Sciences Ltd: Annual Report to Shareholders

Oct 28, 2024 00:50 ET

Microba Life Sciences Ltd: Letter to Shareholders, Notice of AGM & Proxy Form

Oct 28, 2024 00:48 ET

Microba Life Sciences Ltd: Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar

Oct 22, 2024 18:24 ET